Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children

Treatment Side Effects Clinical Trial

— PH  

Official title:

Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04185194
• Other study ID #: P.T.REC/012/001708
• Status: Completed
• Phase: Phase 1
• Start date: January 1, 2019
• Est. completion date: March 1, 2019

Study information

• Verified date: December 2019
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A topical anesthetic gel lidocaine has been widely used as a local anesthetic to reduce the pain and discomfort. It provides local analgesia by blocking the initiation and transmission of impulses. Lidocaine topical anesthetic gel allows the use of high concentrations of the anesthetic bases without concern about local irritation, uneven absorption or systemic toxicity (Argoff, 2000 ). So, the aim of this study is to compare between the effect of lidocaine phonophoresis and pulsed ultrasound in myofascial pain syndrome in swimmers children.

Description:

Fourty five children (athletic swimmers) participated in this study, and were classified into three groups ; First control group A : this group consisted of fifteen children were receiving traditional physical therapy program. Second study group B: this group consisted of fifteen children were receiving pulsed ultrasound in addition to traditional physical therapy program as the same as in group A. Third study group C: this group consisted of fifteen children were receiving lidocaine phonophoresis in addition to traditional physical therapy program as the same as in group A. Treatment program in the three groups applied three times a week for three successive months. The study was done in the outpatient clinic of Ismailiy Sporting Club, Ismailia, Egypt.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: March 1, 2019
• Est. primary completion date: January 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 14 Years

Eligibility

Inclusion Criteria:

• • Age range from 10 to 14 years.

• All children have regional neck pain complaint.

• Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I ) ? The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005)

Exclusion Criteria:

• • Neurological disorders.

• Dermatological disorders.

• Acute trauma prior to the study.

• Fibromyalgia, systemic disease and drug allergy history were excluded from the study.

• Having myofascial trigger points injection.

• Chronic pain in both sides of the body.

Related Conditions & MeSH terms

• Fibromyalgia
• Myofascial Pain Syndromes
• Treatment Side Effects

Intervention

Drug:
• Lidocaine
transmission of the drug molecules to the underlying muscles

Device:
• pulsed ultrasound
using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain

Other:
• especially designed physical therapy program
by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius

Locations

Country	Name	City	State
Egypt	faculty of physical therapy,Cairo University	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	interleukin 6	measurement of interleukin 6 cncentration in blood plasma	three months